EXAGEN INC. - COMMON S

Exagen Inc. and Johns Hopkins University Announce License Agreement for Novel Patented Lupus Nephritis Biomarkers

09 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

02 Nov 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023

30 Oct 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Announces Acceptance of Multiple Abstracts at ACR 2023 Annual Meeting

28 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference

12 Sep 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Strong Second Quarter 2023 Results

07 Aug 2023 07:00:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference

26 Jul 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2023 Financial Results on August 7, 2023

25 Jul 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 43rd Annual Growth Stock Conference

30 May 2023 08:00:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports First Quarter 2023 Results

15 May 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Announces Campaign for Lupus Awareness Month

01 May 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen to Announce First Quarter 2023 Financial Results on May 15, 2023

24 Apr 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results

20 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023

06 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in Upcoming March Conferences

27 Feb 2023 08:00:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

30 Jan 2023 15:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

23 Jan 2023 08:00:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2022 Results

14 Nov 2022 15:05:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

08 Nov 2022 15:05:02 By Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022

31 Oct 2022 15:05:00 By Nasdaq GlobeNewswire